| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |